Innovation
12 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 4,522 times.
| Year | Filings |
|---|---|
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 12 |
| 2026 | 2 |
Investor mix
16 investors on record; lead investors include RA Capital Management, Novartis Venture Fund, Pfizer.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 50% |
| Private equity | 1 | 6% |
| Other / undisclosed | 7 | 44% |